King’s Lynn Implements CMS for Chemotherapy ePrescribing
The Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust has signed a contract with JAC to implement CMS (Chemotherapy Management System) to support the full range of Systemic Anti-Cancer Therapies (SACT) offered by the Trust.
The Queen Elizabeth Hospital is one of the best cancer treatment facilities in the UK. The Trust has a ‘Charter Mark’, award-winning Day Surgery Centre and a nationally recognised Radiology Department that is one of only five units to have achieved the Imaging Standards Accreditation Scheme status.
A broad multi-disciplinary team from Oncology, Haematology, Pharmacy, Cancer Services, ICT and Business Intelligence selected JAC’s CMS as the solution of choice after evaluating all the established chemotherapy ePrescribing suppliers on the market.
“The Trust needed an integrated, easy to use and straight forward system that is capable of being configured locally to reflect our workflows.”
Clinical Director of Oncology and Non-Acute Services, and Clinical Lead for the project, Dr Lisa Cooke said: “The Trust’s Oncology professionals agreed their overarching need was to close the medicines management ‘loop’ for chemotherapy by linking ePrescribing, appointments scheduling and aseptic production within the pharmacy with the Trust’s existing clinical systems. By closing the ‘loop’, opportunities to deliver improved patient care will become more accessible to the Trust’s Oncology professionals and improvements in clinical outcomes and patient safety will be more easily measured.”
Head of Business Intelligence and IM&T Programmes at the Trust, Mariza Wilson, said: “The Trust needed an integrated, easy to use and straight forward to implement web-based system. A system which is capable of being configured locally by Trust staff to reflect our redesigned and newly optimised workflows in Oncology, Haematology and the Chemotherapy Pharmacy.”
“The system also needed to be compatible with the Trust’s existing IT architecture as it was going to be interfaced with our existing clinical and administrative systems, including reporting. The fact that CMS comes ready equipped as a standard with full SACT dataset reporting capability will help the Trust with automating its national returns.”
Once fully deployed, CMS will not only assist the Trust in continuing to improve patients’ experiences, but will also enable the Trust to realise other non-clinical organisational benefits such as: improved and more flexible workflow with additional decision points within a request procedure;
reduced drug wastage by linking patients’ appointment schedules to the chemotherapy production schedules in real-time; and greater revenue generating opportunities based on better scheduling and increased patient throughput.
Regarding the new ePrescribing contract with the Trust, CEO at JAC, Rob Tysall-Blay, said: “We are delighted to be working in partnership with King’s Lynn NHS Foundation Trust towards our shared vision for a fully integrated closed loop medicines management solution, which reaches beyond the need for ePrescribing only.”Read More